BornToSell review
Updated September 29, 2026 · BrokerCue Editorial Team · Facts checked September 28, 2026
We earn a commission when you sign up through links on this site. Partner status can affect where a brand appears in our rankings.
Our verdict
BornToSell suits equity investors who focus on stocks and ETFs and want screening, tracking and newsletter ideas in a browser workspace. Pricing starts at $59.95 with trial access lasting 14, so readers can assess fit before paying.
Key facts
- Best for
- Equity income researchers focused on stocks and ETFs
- Price from
- $59.95 (Source, checked September 28, 2026)
- Free plan
- No (Source, checked September 28, 2026)
- Free trial length
- 14 days (Source, checked September 28, 2026)
- Tool type
- Screener, Portfolio-tracker, Newsletter (Source, checked September 28, 2026)
- Markets
- Stocks, ETFs (Source, checked September 28, 2026)
- Platforms
- Web (Source, checked September 28, 2026)
- Legal entity
- Born To Sell Options, LLC (Source, checked September 28, 2026)
- Headquarters
- United States (Source, checked September 28, 2026)
- Founded
- 2010 (Source, checked September 28, 2026)
- Support channels
- Email, Phone (Source, checked September 28, 2026)
- Pricing model
- Free trial
- Official website
- borntosell.com
Apps and profiles
- Elsewhere
- XLinkedInfacebook.comyoutube.com
Pros and cons
Pros
- Trial access through free trial lasting 14 lets you review the service before paying $59.95
- Focused coverage of stocks and ETFs suits equity income research without unrelated asset classes
- Combined toolkit across screener, portfolio tracker and newsletter supports screening, monitoring and ongoing ideas in a single subscription
- Direct human support through email and phone is helpful compared with email only research services
Cons
- Free plan is no, so continued use after the trial requires a paid subscription at $59.95
- Coverage is limited to stocks and ETFs, without broader asset classes for diversification research
- Access is web based through web, without additional platform options for day to day use
- Pricing starts at $59.95, which is higher than LemurTrade at $9
Who it suits
- Investors focused on stocks and ETFs who want covered call research in a single place
- Subscribers who value screening plus tracking and newsletter content through web
- Readers comfortable contacting support through email and phone when questions arise
Who should look elsewhere
- Readers wanting ongoing access without payment should consider The Oxford Club because Free plan is yes there
- Readers wanting a lower priced entry point should consider LemurTrade because pricing starts at $9
- Readers wanting broader market coverage beyond stocks and ETFs should look elsewhere because BornToSell covers stocks and ETFs
Everyday use
Daily work happens through web, so research, watchlists and newsletter reading stay inside a browser workspace. That approach keeps setup simple for readers who prefer desktop review rather than installing or maintaining separate software. Support is available through email and phone, giving a written route for product questions and a spoken route for account or billing matters. The combination suits a steady routine of screening ideas, checking tracked positions and following up by email or phone when help is needed.
How it compares on our data
On trial length, BornToSell is placed at 2 among 5 ranked brands in this comparison. That placement helps readers see how much evaluation time is available before choosing a paid plan. On starting price, the service is placed at 6 among 7 ranked brands in this comparison. Taken together, the two placements describe a service with a defined trial window and a mid range entry price within this peer group.
Fees and costs
Pricing starts at $59.95 for access to the research toolkit. Free plan is no, so there is no ongoing unpaid tier for regular screening or tracking. Trial access lasts 14, which provides a limited window to assess coverage, alerts and portfolio features before subscribing. Readers should weigh the starting price against the focused equity coverage and decide whether the trial period gives enough time to judge fit.
The company behind it
The service is operated by Born To Sell Options, LLC, which is the entity named in the service terms. The business is based in the United States, giving clarity on operating location for account and support correspondence. The founding year is 2010, indicating an established history in options income research. Customer contact is provided through email and phone, so billing questions and product queries can be raised directly with the company team.
How BornToSell compares
9.0 vs 9.0
9.0 vs 9.4
9.0 vs 8.7
MarketScreener
9.0 vs 9.4
9.0 vs 8.7
9.0 vs 9.0
9.0 vs 9.3
9.0 vs 8.7
9.0 vs 8.6
9.0 vs 9.2
9.0 vs 8.7
Kitco
9.0 vs 9.1
9.0 vs 9.0
9.0 vs 9.0Pepperstone
Vaulted
wikifolio.com
Intellectia
Winvest
Libertex International
XM VN
Frequently asked questions
How much does BornToSell cost?+
Paid access starts at $59.95. Free plan is no, so you need a subscription to keep using the service after the trial period ends. Check the plan terms carefully before the trial expires to avoid an unwanted charge.
Does BornToSell offer a trial or free access?+
Trial access lasts 14 under the free trial model. It gives time to review screening, tracking and newsletter content before paying. Free plan is no, so the trial is the only way to look inside before subscribing.
Which markets does BornToSell cover?+
The service covers stocks and ETFs. That focus suits equity investors who concentrate on listed shares and exchange traded products. If you research other asset classes, another tool with wider coverage may be more appropriate.
What tools are included in the subscription?+
The toolkit includes screener, portfolio tracker and newsletter. Together they support idea generation, position monitoring and ongoing income ideas by email. Access is provided through web, so you can work from a browser without installing software.
How do you access BornToSell day to day?+
Access is provided through web. That setup suits desktop research, watchlist reviews and newsletter reading from a browser. Readers who prefer dedicated mobile software should consider whether browser access meets their routine.
Who runs BornToSell and where is it based?+
The provider is Born To Sell Options, LLC, based in the United States. The business dates from 2010. Support is available through email and phone, which gives direct contact routes for billing and product questions.
How can you get help with your account?+
Support is available through email and phone. You can write for product help or call for more urgent account questions. The web setup through web means most research and account queries can be handled remotely.
Sources
- borntosell.com/about checked September 28, 2026
Backs: Headquarters
“Las Vegas, NV 89117”
- borntosell.com/contact checked September 28, 2026
Backs: Support channels
“support@borntosell.com tel: (800) 434-6980”
- borntosell.com/features checked September 28, 2026
Backs: Tool type
“Search all available covered calls instantly”
- borntosell.com/free-trial checked September 28, 2026
Backs: Founded, Free trial length, Markets, Pricing model, Platforms, Price from
“Since 2010, we have helped thousands”
- borntosell.com/terms checked September 28, 2026
Backs: Free plan, Legal entity
“it is not free, except for the 2 week free trial period”
Compiled from 5 source pages, checked September 28, 2026. We did not open an account.